265 related articles for article (PubMed ID: 32250198)
1. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
Wade C; Wells JM
Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198
[TBL] [Abstract][Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Sessa M; Mascolo A; Rasmussen DB; Kragholm K; Jensen MT; Sportiello L; Rafaniello C; Tari GM; Pagliaro C; Andersen M; Rossi F; Capuano A
Sci Rep; 2019 Aug; 9(1):11465. PubMed ID: 31391573
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) - Study protocol from a randomized controlled trial.
Sundh J; Magnuson A; Montgomery S; Andell P; Rindler G; Fröbert O;
Trials; 2020 Jan; 21(1):123. PubMed ID: 32000825
[TBL] [Abstract][Full Text] [Related]
5. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
6. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
[TBL] [Abstract][Full Text] [Related]
7. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
Zvizdic F; Begic E; Mujakovic A; Hodzic E; Prnjavorac B; Bedak O; Custovic F; Bradaric H; Durak-Nalbantic A
Med Arch; 2019 Apr; 73(2):72-75. PubMed ID: 31391690
[TBL] [Abstract][Full Text] [Related]
9. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
11. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
Karoli NA; Rebrov AP
Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
[TBL] [Abstract][Full Text] [Related]
12. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
Du Q; Sun Y; Ding N; Lu L; Chen Y
PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
van der Woude HJ; Zaagsma J; Postma DS; Winter TH; van Hulst M; Aalbers R
Chest; 2005 Mar; 127(3):818-24. PubMed ID: 15764762
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
[TBL] [Abstract][Full Text] [Related]
16. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
[TBL] [Abstract][Full Text] [Related]
18. Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence.
Baou K; Katsi V; Makris T; Tousoulis D
Curr Hypertens Rev; 2021; 17(3):196-206. PubMed ID: 33302840
[TBL] [Abstract][Full Text] [Related]
19. Can beta-blockers be used for people with COPD?
Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
[TBL] [Abstract][Full Text] [Related]
20. Use of beta-blockers in patients with COPD.
Andrus MR; Holloway KP; Clark DB
Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]